Role of glyoxalase i in the proliferation and apoptosis control of human LNCaP and PC3 prostate cancer cells

Prostate

Volumn 73, Issue 2, 2013, Pages 121-132

  Antognelli, Cinzia ^a   Mezzasoma, Letizia ^a   Fettucciari, Katia ^a   Mearini, Ettore ^a   Talesa, Vincenzo N ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

apoptosis; argpyrimidine; cell proliferation; glyoxalase I; methylglyoxal; prostate cancer

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTOYLGLUTATHIONE LYASE;

APOPTOSIS; ARTICLE; BIOASSAY; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SPECTROPHOTOMETRY; WESTERN BLOTTING;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; HUMANS; LACTOYLGLUTATHIONE LYASE; MALE; MITOCHONDRIAL PROTEINS; NF-KAPPA B; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84871623538     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22547     Document Type: Article

References (43)

1. Thornalley PJ,. The glyoxalase system: New developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem J 1990; 269: 1-11.
2. Beisswenger PJ, Howell SK, Nelson RG, Mauer M, Szwergold BS,. Alpha-oxoaldehyde metabolism and diabetic complications. Biochem Soc Trans 2003; 31: 1358-1363.
3. Kim KM, Kim YS, Jung DH, Lee J, Kim JS,. Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose. Exp Cell Res 2012; 318: 152-159.
4. van Heijst JW, Niessen HW, Hoekman K, Schalkwijk CG,. Advanced glycation end products in human cancer tissues: Detection of Nepsilon-(carboxymethyl) lysine and argpyrimidine. Ann N Y Acad Sci 2005; 1043: 725-733.
5. Kim J, Kim OS, Kim CS, Kim NH, Kim JS,. Cytotoxic role of methylglyoxal in rat retinal pericytes: Involvement of a nuclear factor-kappaB and inducible nitric oxide synthase pathway. Chem Biol Interact 2010; 188: 86-93.
6. Szent-Gyorgi A, Egyud LG, McLaughlin JA,. Ketoaldehydes and cell division. Science 1967; 155: 539-541.
7. Gillespie E,. The mechanism of breakdown of tubulin in vitro. FEBS Lett 1975; 58: 119-121.
8. Principato GB, Locci P, Rosi G, Talesa V, Giovannini E,. Activity changes of glyoxalases I-II and glutathione reductase in regenerating rat liver. Biochem Int 1983; 6: 249-255.
9. Rulli A, Carli L, Romani R, Baroni T, Giovannini E, Rosi G, Talesa V,. Expression of glyoxalase I and II in normal and breast cancer tissues. Breast Cancer Res Treat 2001; 66: 67-72.
10. Antognelli C, Baldracchini F, Talesa VN, Costantini E, Zucchi A, Mearini E,. Overexpression of glyoxalase system enzymes in human kidney tumor. Cancer J 2006; 12: 222-228.
11. Bair WB III, Cabello CM, Uchida K, Bause AS, Wondrak GT,. GLOI overexpression in human malignant melanoma. Melanoma Res 2010; 20: 85-96.
12. Thornalley PJ, Rabbani N,. Glyoxalase in tumorigenesis and multidrug resistance. Semin Cell Dev Biol 2011; 22: 318-325.
13. Paulus C, Kollner B, Jacobsen HJ,. Physiological and biochemical characterization of glyoxalase I, a general marker for cell proliferation, from a soybean cell suspension. Planta 1993; 189: 561-566.
14. Nakadate Y, Uchida K, Shikata K, Yoshimura S, Azuma M, Hirata T, Konishi H, Kiyama H, Tachibana T,. The formation of argpyrimidine, a methylglyoxal-arginine adduct, in the nucleus of neural cells. Biochem Biophys Res Commun 2009; 378: 209-212.
15. Mearini E, Romani R, Mearini L, Antognelli C, Zucchi A, Baroni T, Porena M, Talesa VN,. Differing expression of enzymes of the glyoxalase system in superficial and invasive bladder carcinomas. Eur J Cancer 2002; 38: 1946-1950.
16. Cabello CM, Bair WB III, Bause AS, Wondrak GT,. Antimelanoma activity of the redox dye DCPIP (2,6-dichlorophenolindophenol) is antagonized by NQO1. Biochem Pharmacol 2009; 78: 344-354.
17. User Bulletin No 2. ABI prism 7700 sequence detection system (1997) The Perkin Elmer Corporation (P/N 4303859 Rev A Stock No 777802 001).
18. Fettucciari K, Fetriconi I, Mannucci R, Nicoletti I, Bartoli A, Coaccioli S, Marconi P,. Group B streptococcus induces macrophage apoptosis by calpain activation. J Immunol 2006; 176: 7542-7556.
19. Mannervik B, Aronsson AC, Marmstal E, Tibellin G,. Glyoxalase I (rat liver). In:, Jakoby WB, editor. Methods in enzymatic analysis. New York: Academic Press; 1981. pp. 297-301.
20. Chaplen FW, Fahl WE, Cameron DC,. Method for determination of free intracellular and extracellular methylglyoxal in animal cells grown in culture. Anal Biochem 1996; 238: 171-178.
21. Tso CL, McBride WH, Sun J, Patel B, Tsui KH, Paik SH, Gitlitz B, Caliliw R, van Ophoven A, Wu L, deKernion J, Belldegrun A,. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Cancer J 2000; 6: 220-233.
22. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C,. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139: 271-279.
23. Gerashchenko BI, Azzam EI, Howell RW,. Characterization of cell-cycle progression and growth of WB-F344 normal rat liver epithelial cells following gamma-ray exposure. Cytometry 2004; 61: 134-141.
24. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschi T,. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-498.
25. Gawlowski T, Stratmann B, Stork I, Engelbrecht B, Brodehl A, Niehaus K, Korfer R, Tschoepe D, Milting H,. Heat shock protein 27 modification is increased in the human diabetic failing heart. Hormon Metab Res 2009; 41: 594-599.
26. Folini M, Pennati M, Zaffaroni N,. RNA interference-mediated validation of genes involved in telomere maintenance and evasion of apoptosis as cancer therapeutic targets. Methods Mol Biol 2009; 487: 303-330.
27. Yamagishi S, Inagaki Y, Amano S, Okamoto T, Takeuchi M, Makita Z,. Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties. Biochem Biophys Res Commun 2002; 296: 877-882.
28. Honda S, Farboud B, Hjelmeland L, Handa J,. Induction of an aging mRNA retinal pigment epithelial cell phenotype by matrix-containing advanced glycation end products in vitro. Investig Ophthalmol Vis Sci 2001; 42: 2419-2425.
29. Alikhani Z, Alikhani M, Boyd CM, Nagao K, Trackman PC, Graves DT,. Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways. J Biol Chem 2005; 280: 12087-12095.
30. Reber F, Geffarth R, Kasper M, Reichenbach A, Schleicher E, Sienger A, Funk R,. Graded sensitiveness of the various retinal neuron populations on the glyoxal-mediated formation of advanced glycation end products and ways of protection. Graefes Arch Clin Exp Ophthalmol 2003; 241: 213-225.
31. Wang L, Yu CJ, Liu W, Cheng LY, Zhang YN,. Rosiglitazone protects neuroblastoma cells against advanced glycation end products-induced injury. Acta Pharmacol Sin 2011; 32: 991-998.
32. Kaufmann SH, Hengartner MO,. Programmed cell death: Alive and well in the new millennium. Trends Cell Biol 2001; 11: 526-534.
33. Baldwin AS,. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 2001; 107: 241-246.
34. Lindholm PF, Bub J, Kaul S, Shidham VB, Kajdacsy-Balla A,. The role of constitutive NF-kappaB activity in PC-3 human prostate cancer cell invasive behavior. Clin Exp Metastasis 2000; 18: 471-479.
35. Suh J, Payvandi F, Edelstein LC, Amenta PS, Zong WX, Gélinas C, Rabson AB,. Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells. Prostate 2002; 52: 183-200.
36. Shukla S, Gupta S,. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: Correlation with down-regulation of NF-kappaB-responsive genes. Clin Cancer Res 2004; 10: 3169-3178.
37. Gasparian AV, Yao YJ, Kowalczyk D, Lyakh LA, Karseladze A, Slaga TJ, Budunova IV,. The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells. J Cell Sci 2002; 115: 141-151.
38. Baeuerle PA, Baltimore D,. I kappa B: A specific inhibitor of the NF-kappa B transcription factor. Science 1988; 242: 540-546.
39. Rabbani N, Thornalley PJ,. Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome. Amino Acids 2012; 42: 1133-1142.
40. Boulanger E, Wautier MP, Gane P, Mariette C, Devuyst O, Wautier JL,. The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products. Nephrol Dial Transplant 2004; 19: 2208-2216.
41. Kashani-Sabet M,. Tumor progression by immune evasion in melanoma: Role of the programmed cell death-1/programmed cell death-1 ligand 1 interaction. Cancer 2010; 116: 1623-1625.
42. Zivny J, Klener P Jr, Pytlik R, Andera L,. The role of apoptosis in cancer development and treatment: Focusing on the development and treatment of hematologic malignancies. Curr Pharm Des 2010; 16: 11-33.
43. Kajiwara T, Takeuchi T, Ueki T, Moriyama N, Ueki K, Kakizoe T, Kawabe K,. Effect of bcl-2 overexpression in human prostate cancer cells in vitro and in vivo. Int J Urol 1999; 6: 520-525.